|
The following is a review of diagnostic product developments worldwideThe information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.
Product developments in November 2004
Avitar, Inc. launched the ORALscreen DRUGOMETER, a one-step, oral fluid drug test. The DRUGOMETER is administered like a thermometer. The ORALscreen DRUGOMETER is available in limited quantities, with volume shipments due in January 2005. Pricing starts at $23.95 per unit. Cellomics, Inc. and BD Biosciences entered into a non-exclusive, worldwide patent license agreement that provides BD with Cellomics' core High Content Screening patent portfolio that includes both broad claims to HCS technology and specific classes of HCS assays such as cytoplasm-nuclear translocation, characterization of cellular toxicity, and receptor internalization. BD plans to incorporate Cellomics' technology in its flow and image cytometry product lines. Corgenix Medical Corporation and AspirinWorks, a division of Creative Clinical Concepts, Inc. entered into a license agreement with McMaster University, Hamilton, Ontario, providing Corgenix and CCC exclusive rights to the propriety technology owned by McMaster for the development, manufacturing and marketing of innovative diagnostic tests specific to the pathway by which aspirin acts on platelets. This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance. Glycominds launched a kit for inflammatory bowel diseases based on Glycominds expertise in the area of glycomics and the use of sugar molecules as diagnostic probes in blood samples. HealtheTech Inc. has developed a 10 minute breath test using a handheld device to measure oxygen consumption which provides a precise number reflecting an individual's metabolic rate or metabolic fingerprint. IRIS International, Inc. introduced the iQ200 Sprint Automated Urinalysis System, a high- throughput analyzer designed for high-volume clinical reference laboratories and hospitals. The analyzer can be operated as a standalone unit or integrated with the Arkray AUTION MAX AX-4280 Automated Urine Chemistry Analyzer. Meridian Bioscience, Inc. intends to acquire O.E.M. Concepts, Inc. O.E.M. Concepts manufactures and distributes specialized biologicals for the diagnostic, pharmaceutical, and research markets. The acquisition provides added technologies to Meridian's Life Science business. Polymedco, Inc. introduced the OC Auto Micro 80 analyzer an FDA-cleared immunochemical test to detect the presence of blood in stool samples. Response Biomedical Corp. and 3M Company's Medical Division entered into a co-development agreement whereby 3M will fund the development of a new rapid, point-of-care microbiology test in the area of infection prevention based on Response Biomedical's RAMP technology. The parties intend to enter into a further supply agreement whereby Response Biomedical will manufacture and 3M will exclusively market a line of microbiology tests.
Product Developments Worldwide | Research News | Health Care in Canada Information Technology and Healthcare | Molecular Biology | Links
![[HRule Image]](images/div.jpg){kind=small} Send mail to stratcom@pagebleu.com with questions or comments about this web site.Concept and Design Blue Page
Productions Last modified: December 01, 2004 |
![[Page Banner Image]](images/hprods.gif){kind=small}
